Mazzucato, M;
(2023)
Rethinking Innovation in Drugs: A Pathway to Health for All.
Journal of Law, Medicine and Ethics
, 51
(S2)
pp. 16-20.
10.1017/jme.2023.157.
Preview |
Text
Mazzucato_rethinking-innovation-in-drugs-a-pathway-to-health-for-all.pdf Download (87kB) | Preview |
Abstract
This article discusses the misalignment of the drug innovation model in the US with broader societal goals. The paper calls for a reconfiguration of this model to prioritize the common good and ensure equitable access to health innovations. The article stresses the importance of adopting a mission-oriented approach to shape the drug market, including reforming intellectual property rights.
| Type: | Article |
|---|---|
| Title: | Rethinking Innovation in Drugs: A Pathway to Health for All |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1017/jme.2023.157 |
| Publisher version: | http://dx.doi.org/10.1017/jme.2023.157 |
| Language: | English |
| Additional information: | Creative Commons Creative Common License - CCCreative Common License - BY This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. Copyright © The Author(s), 2024. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics |
| Keywords: | Drug Innovation Policy, Health Equity, Public-Private Collaboration, Intellectual Property Reform, Mission-Oriented Governance |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of the Built Environment UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of the Built Environment > Inst for Innovation and Public Purpose |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10189007 |
Archive Staff Only
 |
View Item |
